Thomas Lu, M.D.
Department of Interventional Radiology, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Diagnostic and Interventional Imaging, UT Health McGovern Medical School, Houston, TX
Education & Training
Degree-Granting Education
| 1996 | New York Medical College, Valhalla, NY, USA, MD, Medicine |
| 1991 | Cornell University, Ithaca, NY, USA, BA, UNKNOWN |
Postgraduate Training
| 2001-2002 | Clinical Fellowship, Vascular and Interventional Radiology, MD Anderson Cancer Center, Houston, TX |
| 1997-2001 | Clinical Residency, Diagnostic Radiology, Harbor-UCLA Medical Center, Torrance, CA |
| 1996-1997 | Clinical Internship, Internal Medicine, Winthrop-University Hospital, Mineola, NY |
Board Certifications
| 2021 | American Board of Radiology, Interventional Radiology/Diagnostic Radiology (Lifetime/No Expiration) |
| 2001 | American Board of Radiology, Diagnostic |
Experience & Service
Administrative Appointments/Responsibilities
Local Site Director Interventional Radiology, Woodlands HALs, The University of Texas MD Anderson Cancer Center, The Woodlands, TX, 2021 - 2024
Patient Experience Officer, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Committee Co-Chair, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center-The Woodlands(Clinical Operations Committee), Houston, TX, 2020 - Present
Committee Member, The University of Texas MD Anderson Cancer Center-The Woodlands (Patient Experience), Houston, TX, 2020 - Present
Committee Member, The University of Texas MD Anderson Cancer Center-The Woodlands(Safety Committee), Houston, TX, 2020 - Present
Committee Member, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center(IR Search Chair Advisory Committee), Houston, TX, 2018 - Present
Other Appointments/Responsibilities
Committee Member, Diagnostic Imaging Faculty Functional Committee, Houston, TX, 2022 - Present
HALS Steering Committee Member, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Chief of Radiology, Park Plaza Hospital, Houston, TX, 2010 - 2012
Medical Executive Committee Member, Park Plaza Hospital, Houston, TX, 2010 - 2012
Credentials Committee Member, Park Plaza Hospital, Houston, TX, 2010 - 2012
Physician Radiologist, Synergy Radiology Associates (Formerly Southwest Radiology Association), Houston, TX, 2002 - 2018
Institutional Committee Activities
Member, Credentials Committee of the Medical Staff, 2023 - 2026
Interventional Radiology Senator, Faculty Senate, 2019 - 2024
Honors & Awards
| 2017 | Letter of Recognition from Medical Staff Peer Review committee, Memorial Hermann Cypress Hospital |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Abdelsalam ME, Mecci N, Awad A, Bassett RL, Odisio BC, Habibollahi P, Lu T, Irwin D, Karam JA, Matin SF, Ahrar K. Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center Experience. Cancers (Basel) 16(10), 2024. e-Pub 2024. PMID: 38791894.
- Abdelsalam ME, Lu T, Baiomy A, Awad A, Odisio BC, Habibollahi P, Irwin D, Karam JA, Matin SF, Stafford J, Ahrar K. Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experience. Eur Radiol. e-Pub 2024. PMID: 38400904.
- Abdelsalam ME, Hudspeth TN, Leonards L, Kusin SB, Buckley JR, Bassett R, Awad A, Karam JA, Matin SF, Lu T, Ahrar K. Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy. Eur Urol Open Sci 57(57):45-50, 2023. e-Pub 2023. PMID: 38020520.
- Abdelsalam ME, Awad A, Baiomy A, Irwin D, Karam JA, Matin SF, Sheth RA, Habibollahi P, Odisio BC, Lu T, Ahrar K. Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience. Cancers (Basel) 15(3):909, 2023. e-Pub 2023. PMID: 36765867.
Abstracts
- Abdelsalam M, Awad A, Lu T, Karam J, Matin S, Ahrar K. Effectiveness of Radiofrequency Ablation for Biopsy Proven T1a Renal Cell Carcinoma (RCC) Greater than or Equal to 3cm. SIR, 2023.
- Abdelsalam M , Mecci N , Awad A , Lu T , Matin S , Karam J , Ahrar K. The 10 Years Survival Outcome of MRI Guided Cryoablation for Biopsy Proven T1a Renal Cell Carcinoma (RCC). CIRSE, 2022.
Patient Reviews
CV information above last modified December 09, 2024